Point mutations in human neoplasia
1988; Volume: 154; Issue: 3 Linguagem: Inglês
10.1002/path.1711540302
ISSN1096-9896
AutoresStanley R. Hamilton, Bert Vogelstein,
Tópico(s)Cancer Genomics and Diagnostics
ResumoThe Journal of PathologyVolume 154, Issue 3 p. 205-206 EditorialFree Access Point mutations in human neoplasia Stanley R. Hamilton, Stanley R. Hamilton The Johns Hopkins University School of Medicine and Hospital Baltimore, MD U.S.A.Search for more papers by this authorBert Vogelstein, Bert Vogelstein The Johns Hopkins University School of Medicine and Hospital Baltimore, MD U.S.A.Search for more papers by this author Stanley R. Hamilton, Stanley R. Hamilton The Johns Hopkins University School of Medicine and Hospital Baltimore, MD U.S.A.Search for more papers by this authorBert Vogelstein, Bert Vogelstein The Johns Hopkins University School of Medicine and Hospital Baltimore, MD U.S.A.Search for more papers by this author First published: March 1988 https://doi.org/10.1002/path.1711540302Citations: 6AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat No abstract is available for this article. References 1 Barbacid M. Ras genes. Annu Rev Biochem 1987; 56: 779–827. 10.1146/annurev.bi.56.070187.004023 CASPubMedWeb of Science®Google Scholar 2 Feinberg AP, Vogelstein B, Droller MJ, Baylin SB, Nelkin BD. Mutation affecting the 12th amino acid of the c-Ha-ras oncogene product occurs infrequently in human cancer. Science 1983; 220: 1175–1177. 10.1126/science.6304875 CASPubMedWeb of Science®Google Scholar 3 Needleman SW, Kraus MH, Srivastava SK, Levine PH, Aaronson SA. High frequency of N-ras activation in acute myelogenous leukemia. Blood 1986; 67: 753–757. 10.1182/blood.V67.3.753.753 CASPubMedWeb of Science®Google Scholar 4 Bos JL, Verlaan-de Vries M, van der Eb AJ, et al. Mutations in N-ras predominate in acute myeloid leukemia. Blood 1987; 69: 1237–1241. 10.1182/blood.V69.4.1237.1237 CASPubMedWeb of Science®Google Scholar 5 Bos JL, Fearon ER, Hamilton SR, et al. Prevalence of ras gene mutations in human colorectal cancers. Nature 1987; 327: 293–297. 10.1038/327293a0 CASPubMedWeb of Science®Google Scholar 6 Forrester K, Almoguera C, Han K, Grizzle WE, Perucho M. Detection of high incidence of K-ras oncogenes during human colon tumourigenesis. Nature 1987; 327: 298–303. 10.1038/327298a0 CASPubMedWeb of Science®Google Scholar 7 Hirai H, Kobayashi Y, Mano H, et al. A point mutation at codon 13 of the N-ras oncogene in myelodysplastic syndrome. Nature 1987; 327: 430–432. 10.1038/327430a0 CASPubMedWeb of Science®Google Scholar Citing Literature Volume154, Issue3March 1988Pages 205-206 ReferencesRelatedInformation
Referência(s)